UniProt ID | STXB4_HUMAN | |
---|---|---|
UniProt AC | Q6ZWJ1 | |
Protein Name | Syntaxin-binding protein 4 | |
Gene Name | STXBP4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 553 | |
Subcellular Localization | Cytoplasm. | |
Protein Description | Plays a role in the translocation of transport vesicles from the cytoplasm to the plasma membrane. Inhibits the translocation of SLC2A4 from intracellular vesicles to the plasma membrane by STX4A binding and preventing the interaction between STX4A and VAMP2. Stimulation with insulin disrupts the interaction with STX4A, leading to increased levels of SLC2A4 at the plasma membrane. May also play a role in the regulation of insulin release by pancreatic beta cells after stimulation by glucose (By similarity).. | |
Protein Sequence | MNKNTSTVVSPSLLEKDPAFQMITIAKETGLGLKVLGGINRNEGPLVYIQEIIPGGDCYKDGRLKPGDQLVSVNKESMIGVSFEEAKSIITGAKLRLESAWEIAFIRQKSDNIQPENLSCTSLIEASGEYGPQASTLSLFSSPPEILIPKTSSTPKTNNDILSSCEIKTGYNKTVQIPITSENSTVGLSNTDVASAWTENYGLQEKISLNPSVRFKAEKLEMALNYLGIQPTKEQHQALRQQVQADSKGTVSFGDFVQVARNLFCLQLDEVNVGAHEISNILDSQLLPCDSSEADEMERLKCERDDALKEVNTLKEKLLESDKQRKQLTEELQNVKQEAKAVVEETRALRSRIHLAEAAQRQAHGMEMDYEEVIRLLEAKITELKAQLADYSDQNKESVQDLKKRIMVLDCQLRKSEMARKTFEASTEKLLHFVEAIQEVFSDNSTPLSNLSERRAVLASQTSLTPLGRNGRSIPATLALESKELVKSVRALLDMDCLPYGWEEAYTADGIKYFINHVTQTTSWIHPVMSVLNLSRSEENEEDCSRELPNQKS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Phosphorylation | ---MNKNTSTVVSPS ---CCCCCCCCCCHH | 27.64 | 21712546 | |
6 | Phosphorylation | --MNKNTSTVVSPSL --CCCCCCCCCCHHH | 28.70 | 25159151 | |
7 | Phosphorylation | -MNKNTSTVVSPSLL -CCCCCCCCCCHHHH | 23.92 | 25159151 | |
10 | Phosphorylation | KNTSTVVSPSLLEKD CCCCCCCCHHHHCCC | 12.39 | 25159151 | |
12 | Phosphorylation | TSTVVSPSLLEKDPA CCCCCCHHHHCCCCC | 37.77 | 21712546 | |
16 | Ubiquitination | VSPSLLEKDPAFQMI CCHHHHCCCCCCCEE | 69.82 | 21906983 | |
16 (in isoform 1) | Ubiquitination | - | 69.82 | 21906983 | |
27 | Ubiquitination | FQMITIAKETGLGLK CCEEEEHHHHCCCEE | 52.54 | 21906983 | |
27 (in isoform 1) | Ubiquitination | - | 52.54 | 21906983 | |
60 | Ubiquitination | IPGGDCYKDGRLKPG ECCCCCCCCCCCCCC | 61.10 | - | |
65 | Ubiquitination | CYKDGRLKPGDQLVS CCCCCCCCCCCEEEE | 45.66 | - | |
82 | Phosphorylation | KESMIGVSFEEAKSI CHHHCCCCHHHHHHH | 23.02 | 25159151 | |
99 | Phosphorylation | GAKLRLESAWEIAFI CCEEEHHHHHHHEEE | 43.18 | - | |
151 | Phosphorylation | PEILIPKTSSTPKTN CCEEECCCCCCCCCC | 23.66 | 21712546 | |
156 | Ubiquitination | PKTSSTPKTNNDILS CCCCCCCCCCCCHHH | 65.06 | - | |
157 | Phosphorylation | KTSSTPKTNNDILSS CCCCCCCCCCCHHHC | 40.22 | - | |
163 | Phosphorylation | KTNNDILSSCEIKTG CCCCCHHHCCEEECC | 33.02 | 25159151 | |
164 | Phosphorylation | TNNDILSSCEIKTGY CCCCHHHCCEEECCC | 16.60 | 21815630 | |
168 | Ubiquitination | ILSSCEIKTGYNKTV HHHCCEEECCCCCEE | 17.38 | - | |
208 | Phosphorylation | YGLQEKISLNPSVRF CCCCCCCCCCHHHCH | 32.91 | 28555341 | |
212 | Phosphorylation | EKISLNPSVRFKAEK CCCCCCHHHCHHHHH | 25.50 | 28857561 | |
233 | Ubiquitination | YLGIQPTKEQHQALR HCCCCCCHHHHHHHH | 63.16 | - | |
248 | Ubiquitination | QQVQADSKGTVSFGD HHHHHCCCCCCCHHH | 60.18 | - | |
250 | Phosphorylation | VQADSKGTVSFGDFV HHHCCCCCCCHHHHH | 19.40 | 29214152 | |
252 | Phosphorylation | ADSKGTVSFGDFVQV HCCCCCCCHHHHHHH | 24.29 | 22199227 | |
323 | Ubiquitination | EKLLESDKQRKQLTE HHHHHCHHHHHHHHH | 62.37 | - | |
326 | Ubiquitination | LESDKQRKQLTEELQ HHCHHHHHHHHHHHH | 47.36 | - | |
346 | Phosphorylation | AKAVVEETRALRSRI HHHHHHHHHHHHHHH | 14.03 | 29978859 | |
380 | Ubiquitination | VIRLLEAKITELKAQ HHHHHHHHHHHHHHH | 40.56 | - | |
382 | Phosphorylation | RLLEAKITELKAQLA HHHHHHHHHHHHHHC | 34.26 | 23403867 | |
385 (in isoform 1) | Ubiquitination | - | 28.05 | 21906983 | |
385 | Ubiquitination | EAKITELKAQLADYS HHHHHHHHHHHCCCC | 28.05 | 21906983 | |
391 | Phosphorylation | LKAQLADYSDQNKES HHHHHCCCCCCCHHH | 14.45 | 29496907 | |
392 | Phosphorylation | KAQLADYSDQNKESV HHHHCCCCCCCHHHH | 33.01 | 29496907 | |
396 | Ubiquitination | ADYSDQNKESVQDLK CCCCCCCHHHHHHHH | 45.81 | 2190698 | |
396 (in isoform 1) | Ubiquitination | - | 45.81 | 21906983 | |
421 | Ubiquitination | RKSEMARKTFEASTE CHHHHHHHHHHHHHH | 48.29 | - | |
445 | Phosphorylation | QEVFSDNSTPLSNLS HHHHCCCCCCCCCHH | 36.07 | - | |
446 | Phosphorylation | EVFSDNSTPLSNLSE HHHCCCCCCCCCHHH | 34.21 | - | |
460 | Phosphorylation | ERRAVLASQTSLTPL HHHHHHHCCCCCCCC | 29.81 | 17525332 | |
462 | Phosphorylation | RAVLASQTSLTPLGR HHHHHCCCCCCCCCC | 24.17 | 21082442 | |
463 | Phosphorylation | AVLASQTSLTPLGRN HHHHCCCCCCCCCCC | 23.70 | 17525332 | |
465 | Phosphorylation | LASQTSLTPLGRNGR HHCCCCCCCCCCCCC | 19.08 | 28122231 | |
483 | Ubiquitination | ATLALESKELVKSVR CCHHHCCHHHHHHHH | 45.77 | - | |
487 | Ubiquitination | LESKELVKSVRALLD HCCHHHHHHHHHHHC | 56.72 | - | |
519 | Phosphorylation | KYFINHVTQTTSWIH HHHHHHHHCCCCCHH | 16.79 | 27251275 | |
521 | Phosphorylation | FINHVTQTTSWIHPV HHHHHHCCCCCHHHH | 17.27 | 27251275 | |
522 | Phosphorylation | INHVTQTTSWIHPVM HHHHHCCCCCHHHHH | 16.55 | 27251275 | |
523 | Phosphorylation | NHVTQTTSWIHPVMS HHHHCCCCCHHHHHH | 27.67 | 27251275 | |
545 | Phosphorylation | EENEEDCSRELPNQK CCCHHHHHHCCCCCC | 40.90 | 28985074 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of STXB4_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
99 | S | Phosphorylation |
| - |
99 | S | Phosphorylation |
| - |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of STXB4_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of STXB4_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6 AND SER-10, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6; SER-10 AND THR-465,AND MASS SPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-460 AND SER-463, ANDMASS SPECTROMETRY. |